MK

Mohamadabbas Kausharali Kalyani

Active Director Director DIN 10229677
DIN 10229677 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohamadabbas Kausharali Kalyani

Data last updated:

Mohamadabbas Kausharali Kalyani is a Director at Lakemedel Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10229677
Primary Designation Director
Industry Pharma
First Appointment 06 Jul 2023
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Jul 20232014Active

Board colleagues of Mohamadabbas Kausharali Kalyani

Directorship timeline

Open interactive timeline →
Lakemedel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mohamadabbas Kausharali Kalyani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohamadabbas Kausharali Kalyani

Mohamadabbas Kausharali Kalyani currently holds 1 directorship: Lakemedel Pharmaceuticals Private Limited (Director, since 06 Jul 2023).

Mohamadabbas Kausharali Kalyani was first appointed on 06 Jul 2023 as Director at Lakemedel Pharmaceuticals Private Limited.

The current boards of Mohamadabbas Kausharali Kalyani's companies include Asif Panjwani (Lakemedel Pharmaceuticals Private Limited), Nazim Navrozbhai Kazani (Lakemedel Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available